The global Macrophage Marker Market Growth Accelerated by increasing Demand from Immunology Research
Macrophage markers find extensive applications in molecular
biology and immunology research studies. They help identify the phenotype and
functions of macrophages in specific tissues under healthy and diseased
conditions. The products enable researchers to study the role of macrophages in
various immunological disorders and inflammation. They are essential reagents
used to characterize monocytes, macrophages, and dendritic cells in flow
cytometry and immunohistochemistry experiments.
The global Macrophage Marker Market is estimated to be
valued at US$ 295.15 Mn in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period
2023 to 2031, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The increasing demand from immunology research is expected to drive the market
growth over the forecast period. Macrophage markers play a crucial role in
understanding the immune response and function of macrophages in various
diseases. With the rising incidence of chronic disorders such as cancer and
autoimmune diseases, researchers are focusing on elucidating the pathways
related to macrophage activation and polarization. This is anticipated to
propel the demand for macrophage markers from academic research institutions
and biotechnology companies engaged in drug discovery and development
activities involving macrophage modulation. Advanced labeling and detection
technologies are also fueling the uptake of macrophage markers in research
experiments aimed at phenotyping immune cells.
Segment Analysis
The global
Macrophage Marker market size can be segmented on the basis of marker
type, technology, disease indication, and end user. Among marker type, CD68 is
dominating the market as it is considered as the gold standard for identifying
human macrophages. Between technology, flow cytometry is the most commonly used
technique for detecting macrophage markers due to its high sensitivity and
specificity.
Key Takeaways
The global Macrophage Marker market is expected to witness high growth. The
global Macrophage Marker Market is estimated to be valued at US$ 295.15 Mn in
2023 and is expected to exhibit a CAGR
of 2.7% over the forecast period 2023 to 2031.
Western Europe region is expected to witness fastest growth during forecast
period owing to increasing funding for translational research and biomarker
development projects from government organizations in this region. United
States currently dominates the North American region and is expected to
continue its dominance during forecast period owing to presence of leading
market players and research institutes in the country.
Key players operating in the Macrophage Marker market are BD Biosciences,
Beckman Coulter, Merck KGaA. BD Biosciences is currently dominating the global
market with wide range of monoclonal antibodies for various macrophage markers
like CD14, CD163, etc. Beckman Coulter offers comprehensive portfolio of flow
cytometry panels with fluorescent conjugated monoclonal antibodies against
macrophage markers. Merck KGaA provides reagents and assay kits for detecting
macrophage populations from different body fluids including blood, tissue, etc.
Explore
Our More Blogs Here: https://www.newsstatix.com/macrophage-marker-market-share-and-opportunity-analysis/
Comments
Post a Comment